Global News

goBalto launches study startup solution Select

Thursday, March 31, 2016

goBalto, a provider of cloud-based clinical study startup solutions, has released goBalto Select for optimizing site selection. With this release, goBalto becomes the first life science software vendor to offer a complete end-to-end platform for starting clinical trials, from site feasibility assessment and selection through to activation, with comprehensive metrics to track adherence to timelines and budget.

[Read More]

Helix BioPharma announces CEO swap

Wednesday, March 30, 2016

Dr. Zbigniew Markowski has stepped down, for personal and family reasons, from his positions as chief executive officer of Helix BioPharma and chairman of Helix Polska. Helix BioPharma is a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer. Dr. Sven Rohmann will replace Markowski, effective immediately.

[Read More]

Eurotrials opens office in Mexico

Wednesday, March 30, 2016

Eurotrials, a CRO specialized in Europe and Latin America, is pleased to announce the opening of its new office in Mexico City, Mexico. The new office strengthens the company’s presence in Latin America and further boosts its growth and expansion, providing full operational coverage in this key emergent region.

[Read More]

LakePharma partners with Ampersand, acquires Blue Sky BioServices

Wednesday, March 30, 2016

LakePharma, a provider of integrated solutions covering the biologics CRO space, has acquired Blue Sky BioServices, a CRO specializing in protein and antibody production and assay services. The combined company will be known as LakePharma, and is now the largest dedicated biologics CRO in the U.S., providing a broad range of protein and antibody-related development services to the pharmaceutical and biotechnology markets. Blue Sky BioServices is a portfolio company of Ampersand Capital Partners and as part of the transaction, Ampersand made an investment into LakePharma to support growth initiatives. 

[Read More]

WuXi AppTec launches South Korea Branch

Monday, March 28, 2016

WuXi AppTec, an open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and medical device industries, has opened its branch office in Seoul, South Korea, one of the most dynamic life science innovation hubs in the Asia Pacific region.

[Read More]

Orig3n, Sharp Edge Labs ink drug discovery alliance

Monday, March 28, 2016

ORIG3N, a regenerative medicine provider, and Sharp Edge Labs, a drug discovery and development company focused on genetic disorders, have entered into a drug discovery alliance. As part of the alliance, ORIG3N will make patient-derived cells available to Sharp Edge Labs for use in their drug discovery platform for genetic disorders.

[Read More]

Certara’s Synchrogenix launches AI transparency solution

Monday, March 28, 2016

Certara, a global biosimulation technology-enabled drug development company, has announced that its regulatory and medical consultancy, Synchrogenix, has introduced an artificial intelligence- (AI-) enabled solution to meet the data transparency requirements of the clinical and drug development market. Those detailed requirements were published by the EMA on March 2 as Policy 70.

[Read More]